The levels of circulating vascular endothelial growth factor and soluble Flt-1 in pregnancies complicated by preeclampsia
- PMID: 17297258
- PMCID: PMC2693576
- DOI: 10.3346/jkms.2007.22.1.94
The levels of circulating vascular endothelial growth factor and soluble Flt-1 in pregnancies complicated by preeclampsia
Abstract
To evaluate the role of vascular endothelial growth factor (VEGF) in the pathogenesis of preeclampsia, we measured total VEGF, free VEGF and soluble Flt-1 (sFlt-1) concentrations and determined their relationships. Maternal serum samples were collected from 20 patients with preeclampsia and 20 normotensive women with uncomplicated pregnancies matched with the patients with preeclampsia for gestational age and parity. The serum concentrations of total VEGF (2.39+/-0.75 vs. 0.28+/-0.14) and sFlt-1 (934.5+/-235.5 vs. 298.0+/-161.2) were significantly increased in the patients with preeclampsia compared to the women with uncomplicated pregnancies. However the serum concentration of free VEGF (21.5+/-6.3 vs. 134.0+/-16.3) was lower in patients with preeclampsia. There was a positive correlation between the serum concentrations of total VEGF and sFlt-1 with systolic and diastolic blood pressure, respectively. There was a negative correlation between the serum concentration of free VEGF and systolic and diastolic blood pressure. There was a strong negative correlation between free VEGF and sFlt-1 concentrations. In conclusion, we found VEGF and sFlt-1 were related to the pathogenesis of preeclampsia. Although reduced concentrations of free VEGF might interfere with endothelial cell function and survival, further studies are required to clarify its specific role in the pathogenesis of preeclampsia.
Figures


Similar articles
-
Soluble vascular endothelial growth factor receptor-1 (sFLT-1) mediates downregulation of FLT-1 and prevents activated neutrophils from women with preeclampsia from additional migration by VEGF.Circ Res. 2005 Dec 9;97(12):1253-61. doi: 10.1161/01.RES.0000194324.29363.82. Epub 2005 Nov 3. Circ Res. 2005. PMID: 16269656
-
Soluble vascular endothelial growth factor receptor-1 (sFlt-1) is increased throughout gestation in patients who have preeclampsia develop.Am J Obstet Gynecol. 2004 Oct;191(4):1240-6. doi: 10.1016/j.ajog.2004.03.004. Am J Obstet Gynecol. 2004. PMID: 15507947
-
The relationship between circulating tissue transglutaminase, soluble fms-like tyrosine kinase-1, soluble endoglin and vascular endothelial growth factor in pre-eclampsia.J Hum Hypertens. 2016 Dec;30(12):788-793. doi: 10.1038/jhh.2016.32. Epub 2016 May 12. J Hum Hypertens. 2016. PMID: 27169826
-
[Potential value of placental angiogenic factors as biomarkers in preeclampsia for clinical physicians].Nephrol Ther. 2019 Nov;15(6):413-429. doi: 10.1016/j.nephro.2018.10.005. Epub 2019 Mar 30. Nephrol Ther. 2019. PMID: 30935786 Review. French.
-
A Review of Angiogenic Imbalance in HIV-Infected Hypertensive Disorders of Pregnancy.Curr Hypertens Rep. 2019 Jul 24;21(9):69. doi: 10.1007/s11906-019-0970-7. Curr Hypertens Rep. 2019. PMID: 31342170 Review.
Cited by
-
Predictive value of soluble fms-like tyrosine kinase-1 against placental growth factor for preeclampsia in a Chinese pregnant women population.J Clin Lab Anal. 2019 Jun;33(5):e22861. doi: 10.1002/jcla.22861. Epub 2019 Feb 13. J Clin Lab Anal. 2019. PMID: 30758082 Free PMC article.
-
High-throughput methylome analysis reveals differential methylation for early and late onset preeclampsia for mothers and their children.Physiol Genomics. 2024 Mar 1;56(3):276-282. doi: 10.1152/physiolgenomics.00058.2023. Epub 2024 Jan 8. Physiol Genomics. 2024. PMID: 38189116 Free PMC article.
-
Plasma levels of angiopoietin-2, VEGF-A, and VCAM-1 as markers of bevacizumab-induced hypertension: CALGB 80303 and 90401 (Alliance).Angiogenesis. 2022 Feb;25(1):47-55. doi: 10.1007/s10456-021-09799-1. Epub 2021 May 24. Angiogenesis. 2022. PMID: 34028627 Free PMC article. Clinical Trial.
-
Predictive value of the sFlt‑1/PlGF ratio in women with suspected preeclampsia: An update (Review).Int J Mol Med. 2023 Oct;52(4):89. doi: 10.3892/ijmm.2023.5292. Epub 2023 Aug 18. Int J Mol Med. 2023. PMID: 37594116 Free PMC article.
-
The impact of different endometrial preparation protocols on obstetric and neonatal complications in frozen-thawed embryo transfer: a retrospective cohort study of 3,458 singleton deliveries.Reprod Biol Endocrinol. 2022 Sep 22;20(1):141. doi: 10.1186/s12958-022-01009-x. Reprod Biol Endocrinol. 2022. PMID: 36138458 Free PMC article.
References
-
- Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, Schisterman EF, Thadhani R, Sachs BP, Epstein FH, Sibai BM, Sukhatme VP, Karumanchi SA. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med. 2004;350:672–683. - PubMed
-
- Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, Libermann TA, Morgan JP, Sellke FW, Stillman IE, Epstein FH, Sukhatme VP, Karumanchi SA. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest. 2003;111:649–658. - PMC - PubMed
-
- Lee GS, Lee JK, Han WS, Lee Y, Kim SJ, Rha JG, Kim SP, Namkoong SE. The expression of vascular endothelial growth factor, platelet-derived growth factor and intercellular adhesion molecule in severe preeclamptic placenta. Korean J Obstet Gynecol. 2003;46:606–611.
-
- Jelkmann W. Pitfalls in the measurement of circulating vascular endothelial growth factor. Clin Chem. 2001;47:617–623. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources